These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 30410041)

  • 1. A Randomized Controlled Trial of TELEmedicine for Patients with Inflammatory Bowel Disease (TELE-IBD).
    Cross RK; Langenberg P; Regueiro M; Schwartz DA; Tracy JK; Collins JF; Katz J; Ghazi L; Patil SA; Quezada SM; Beaulieu D; Horst SN; Russman K; Riaz M; Jambaulikar G; Sivasailam B; Quinn CC
    Am J Gastroenterol; 2019 Mar; 114(3):472-482. PubMed ID: 30410041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory Bowel Disease Telemedicine Clinical Trial: Impact of Educational Text Messages on Disease-Specific Knowledge Over 1 Year.
    Abutaleb A; Buchwald A; Chudy-Onwugaje K; Langenberg P; Regueiro M; Schwartz DA; Tracy JK; Ghazi L; Patil SA; Quezada SM; Russman KM; Quinn CC; Jambaulikar G; Beaulieu DB; Horst S; Cross RK
    Inflamm Bowel Dis; 2018 Sep; 24(10):2191-2197. PubMed ID: 29788137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Telemedicine for Patients With Inflammatory Bowel Disease (TELE-IBD) Clinical Trial: Qualitative Assessment of Participants' Perceptions.
    Quinn CC; Chard S; Roth EG; Eckert JK; Russman KM; Cross RK
    J Med Internet Res; 2019 Jun; 21(6):e14165. PubMed ID: 31162128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TELEmedicine for Patients with Inflammatory Bowel Disease (TELE-IBD): Design and implementation of randomized clinical trial.
    Cross RK; Jambaulikar G; Langenberg P; Tracy JK; Collins JF; Katz J; Regueiro M; Schwartz DA; Quinn CC
    Contemp Clin Trials; 2015 May; 42():132-44. PubMed ID: 25812483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Web-Based Telemanagement System for Improving Disease Activity and Quality of Life in Patients With Complex Inflammatory Bowel Disease: Pilot Randomized Controlled Trial.
    Del Hoyo J; Nos P; Faubel R; Muñoz D; Domínguez D; Bastida G; Valdivieso B; Correcher M; Aguas M
    J Med Internet Res; 2018 Nov; 20(11):e11602. PubMed ID: 30482739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TELEmedicine for Patients With Inflammatory Bowel Disease (TELE-IBD) Does Not Improve Depressive Symptoms or General Quality of Life Compared With Standard Care at Tertiary Referral Centers.
    Schliep M; Chudy-Onwugaje K; Abutaleb A; Langenberg P; Regueiro M; Schwartz DA; Tracy JK; Ghazi L; Patil SA; Quezada S; Russman K; Horst S; Beaulieu D; Quinn C; Jambaulikar G; Cross RK
    Crohns Colitis 360; 2020 Jan; 2(1):otaa002. PubMed ID: 32201859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of TELEmedicine for Inflammatory Bowel Disease on Patient Activation and Self-Efficacy.
    Bilgrami Z; Abutaleb A; Chudy-Onwugaje K; Langenberg P; Regueiro M; Schwartz DA; Tracy JK; Ghazi L; Patil SA; Quezada SM; Russman KM; Quinn CC; Jambaulikar G; Beaulieu DB; Horst S; Cross RK
    Dig Dis Sci; 2020 Jan; 65(1):96-103. PubMed ID: 30604373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in Outcomes Reported by Patients With Inflammatory Bowel Diseases vs Their Health Care Professionals.
    Pittet VEH; Maillard MH; Simonson T; Fournier N; Rogler G; Michetti P;
    Clin Gastroenterol Hepatol; 2019 Sep; 17(10):2050-2059.e1. PubMed ID: 30471455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Landscape of Telemedicine Practice in Inflammatory Bowel Disease.
    Patil SA; Cross RK
    Inflamm Bowel Dis; 2018 Aug; 24(9):1910-1917. PubMed ID: 29718218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic Burden and Health Care Access for Patients With Inflammatory Bowel Diseases in China: Web-Based Survey Study.
    Yu Q; Zhu C; Feng S; Xu L; Hu S; Chen H; Chen H; Yao S; Wang X; Chen Y
    J Med Internet Res; 2021 Jan; 23(1):e20629. PubMed ID: 33399540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical course and outcomes of diagnosing Inflammatory Bowel Disease in children 10 years and under: retrospective cohort study from two tertiary centres in the United Kingdom and in Italy.
    Gasparetto M; Guariso G; Pozza LV; Ross A; Heuschkel R; Zilbauer M
    BMC Gastroenterol; 2016 Mar; 16():35. PubMed ID: 26976427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of Healthcare Utilization Among Veterans with Inflammatory Bowel Disease.
    Tan MC; El-Serag HB; Hou JK
    Dig Dis Sci; 2017 Mar; 62(3):607-614. PubMed ID: 28012103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Gastrointestinal Patient Reported Outcomes Measurement Information System (GI-PROMIS) Symptom Scales in Subjects With Inflammatory Bowel Diseases.
    Kochar B; Martin CF; Kappelman MD; Spiegel BM; Chen W; Sandler RS; Long MD
    Am J Gastroenterol; 2018 Jan; 113(1):72-79. PubMed ID: 28853727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age Modifies the Association Between Depressive Symptoms and Adherence to Self-Testing With Telemedicine in Patients With Inflammatory Bowel Disease.
    Chudy-Onwugaje K; Abutaleb A; Buchwald A; Langenberg P; Regueiro M; Schwartz DA; Tracy JK; Ghazi L; Patil SA; Quezada S; Russman K; Horst S; Beaulieu D; Quinn C; Jambaulikar G; Cross RK
    Inflamm Bowel Dis; 2018 Nov; 24(12):2648-2654. PubMed ID: 29846623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Low Immunoglobulin G Levels on Disease Outcomes in Patients with Inflammatory Bowel Diseases.
    Horton N; Wu X; Philpott J; Garber A; Achkar JP; Brzezinski A; Lashner BA; Shen B
    Dig Dis Sci; 2016 Nov; 61(11):3270-3277. PubMed ID: 27619393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal study of quality of life and psychological functioning for active, fluctuating, and inactive disease patterns in inflammatory bowel disease.
    Lix LM; Graff LA; Walker JR; Clara I; Rawsthorne P; Rogala L; Miller N; Ediger J; Pretorius T; Bernstein CN
    Inflamm Bowel Dis; 2008 Nov; 14(11):1575-84. PubMed ID: 18512245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telemedicine in inflammatory bowel disease: opportunities and approaches.
    Aguas Peris M; Del Hoyo J; Bebia P; Faubel R; Barrios A; Bastida G; Valdivieso B; Nos P
    Inflamm Bowel Dis; 2015 Feb; 21(2):392-9. PubMed ID: 25437818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefits of implementing a rapid access clinic in a high-volume inflammatory bowel disease center: Access, resource utilization and outcomes.
    Nene S; Gonczi L; Kurti Z; Morin I; Chavez K; Verdon C; Reinglas J; Kohen R; Bessissow T; Afif W; Wild G; Seidman E; Bitton A; Lakatos PL
    World J Gastroenterol; 2020 Feb; 26(7):759-769. PubMed ID: 32116423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of inflammatory bowel disease on Japanese patients' quality of life: results of a patient questionnaire survey.
    Ueno F; Nakayama Y; Hagiwara E; Kurimoto S; Hibi T
    J Gastroenterol; 2017 May; 52(5):555-567. PubMed ID: 27470433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EHealth: self-management in inflammatory bowel disease and in irritable bowel syndrome using novel constant-care web applications. EHealth by constant-care in IBD and IBS.
    Pedersen N
    Dan Med J; 2015 Dec; 62(12):B5168. PubMed ID: 26621403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.